whether the anatomic or biochemical information provided by the
AVAM Center - Soc Nuclear Med
CT and MRI criteria since 1986. Although CT and MRI have been used to differentiate
benign from malignant adrenal masses, many masses remain indeterminate by current …
benign from malignant adrenal masses, many masses remain indeterminate by current …
[CITATION][C] Indeterminate Adrenal Masses—Reply
D Delbeke - Journal of Nuclear Medicine, 2000 - Soc Nuclear Med
CT and MRI criteria since 1986. Although CT and MRI have been used to differentiate
benign from malignant adrenal masses, many masses remain indeterminate by current …
benign from malignant adrenal masses, many masses remain indeterminate by current …
[CITATION][C] Indeterminate adrenal masses
DM Schuster - Journal of Nuclear Medicine, 2000 - Soc Nuclear Med
CT and MRI criteria since 1986. Although CT and MRI have been used to differentiate
benign from malignant adrenal masses, many masses remain indeterminate by current …
benign from malignant adrenal masses, many masses remain indeterminate by current …
PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients
GWL Boland, MA Blake… - American Journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to evaluate a large cohort of patients with
PET/CT to determine whether qualitative (visual) assessment, quantitative standardized …
PET/CT to determine whether qualitative (visual) assessment, quantitative standardized …
Evaluation of adrenal lesions in patients with known malignancies using F18-FDG PET/PET-CT: A multicenter study
1653 Objectives: The purpose of this study was to assess the usefulness of positron
emission tomography (PET) with F18-fluorodeoxyglucose (FDG) in differentiating benign …
emission tomography (PET) with F18-fluorodeoxyglucose (FDG) in differentiating benign …
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation
C Ansquer, S Scigliano, E Mirallié, D Taïeb… - European journal of …, 2010 - Springer
Purpose This prospective multicentre study assesses the usefulness of FDG PET/CT in
characterizing and making the therapeutic decision concerning adrenal tumours that are …
characterizing and making the therapeutic decision concerning adrenal tumours that are …
18F-FDG PET/CT in the evaluation of adrenal masses
U Metser, E Miller, H Lerman, G Lievshitz… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Our purpose was to evaluate the performance of 18F-FDG PET/CT, using data from both the
PET and the unenhanced CT portions of the study, in characterizing adrenal masses in …
PET and the unenhanced CT portions of the study, in characterizing adrenal masses in …
The utility of FDG-PET CT in differentiating malignant from benign adrenal lesions
B Oguz, SS Zuhur, O Karaman, S Velet… - Endocrine …, 2011 - endocrine-abstracts.org
Background: With the increasing use of USG, MRI and CT, adrenal lesions are frequently
found in the daily practice. These lesions may be primary or secondary in origin. However, it …
found in the daily practice. These lesions may be primary or secondary in origin. However, it …
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Y Lu, D Xie, W Huang, H Gong, J Yu - Neoplasma, 2010 - europepmc.org
The aim of this study was to assess the usefulness of integrated (18) F-FDG PET/CT in
differentiating benign from metastatic malignant adrenal masses in patients with lung …
differentiating benign from metastatic malignant adrenal masses in patients with lung …
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI
M Yun, W Kim, N Alnafisi, L Lacorte… - Journal of Nuclear …, 2001 - Soc Nuclear Med
The purpose of this study was to evaluate the ability of 18F-FDG PET to characterize adrenal
lesions in patients with proven or suspected cancers. Methods: A retrospective analysis was …
lesions in patients with proven or suspected cancers. Methods: A retrospective analysis was …